Published in Aliment Pharmacol Ther on February 01, 1993
Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut (1997) 1.53
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol (2002) 1.13
Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut (1997) 0.99
Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci (2012) 0.96
Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.95
16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci (2002) 0.89
Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut (1996) 0.86
Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat. Gut (1998) 0.85
Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy. J Clin Pathol (1997) 0.84
Short term effects of indomethacin on rat small intestinal permeability. Role of eicosanoids and platelet activating factor. Gut (1994) 0.78
Role of neutrophils and mast cells in acute indomethacin-induced small bowel injury in the rat. J Gastroenterol (1997) 0.78
Indomethacin and pancreatic enzymes synergistically damage intestine of rats. Dig Dis Sci (1998) 0.78
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum. BMC Gastroenterol (2002) 0.76
Effect of diet on changes in small intestinal blood flow following intracolonic administration of indomethacin to rats. Dig Dis Sci (2001) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months. Vet Rec (2001) 5.19
A simple clinical colitis activity index. Gut (1998) 4.35
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Reduction in incidence of severe paracetamol poisoning. Lancet (2000) 3.06
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) (2007) 2.55
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol (2000) 2.24
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Rights of possession in human corpses. J Clin Pathol (1997) 2.03
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology (1992) 2.00
Model of medical treatment for duodenal ulcer. Lancet (1981) 1.98
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun (1997) 1.97
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol (1988) 1.96
Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol (1993) 1.94
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut (1977) 1.87
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood (1998) 1.86
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut (1976) 1.82
DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology (1992) 1.80
A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther (1996) 1.79
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
The inappropriate use of acute hospital beds in an inner London District Health Authority. Health Trends (1993) 1.75
Investigation of the gastrointestinal bacterial flora. Clin Gastroenterol (1978) 1.72
Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology (1995) 1.69
Serum -glytamyl transpeptidase activity in liver disease. Gut (1972) 1.69
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.65
Integration of academic and clinical performance-based faculty compensation plans: a system and its impact on an anaesthesiology department. Br J Anaesth (2013) 1.63
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer (2013) 1.60
Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet (1995) 1.58
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
poc1: an Arabidopsis mutant perturbed in phytochrome signaling because of a T DNA insertion in the promoter of PIF3, a gene encoding a phytochrome-interacting bHLH protein. Proc Natl Acad Sci U S A (1999) 1.57
Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol (1982) 1.55
Patency and reintervention rates during routine TIPSS surveillance. Cardiovasc Intervent Radiol (1998) 1.54
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.52
Healing of gastric ulcer during treatment with cimetidine. Lancet (1976) 1.52
Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection. Infect Immun (2001) 1.51
The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther (1991) 1.51
Helicobacter pylori and gastroduodenal secretory function. Gastroenterology (1996) 1.50
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Locum doctors in general practice: motivation and experiences. Br J Gen Pract (1999) 1.48
Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol (1995) 1.46
The initial care of newborn infants and subsequent hay fever. Allergy (2000) 1.46
Duodenal ulcers that will not heal. Gut (1984) 1.45
Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol (1998) 1.44
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) (1991) 1.42
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
"Selectivity" and "specificity": what do they mean? Gen Pharmacol (1993) 1.40
Management issues for debate: the problems in perspective. Aliment Pharmacol Ther (1993) 1.39
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing? Arch Pathol Lab Med (2005) 1.39
The value of flumazenil in the reversal of midazolam-induced sedation for upper gastrointestinal endoscopy. Aliment Pharmacol Ther (1990) 1.38
Functional characterization of three adenosine receptor types. Br J Pharmacol (1993) 1.35
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology (2001) 1.34
Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol (1991) 1.33
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
A possible vascular factor in the aetiology of duodenal ulceration. Br J Surg (1971) 1.31
Release of acetylcholine and 14 C-glycine from the cat spinal cord in vivo. Br J Pharmacol (1971) 1.30
Health-related behaviors of survivors of childhood cancer. Med Pediatr Oncol (1995) 1.28
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology (1982) 1.27